Apply for a Grant

The FAST-TRAC (Targeted Research to Advance a Cure)  Awards are designed to catalyze the creation or enhancement of potential treatments for AS with particular emphasis placed on gene modification, disease modification, and symptom-alleviating therapeutics, along with diverse platforms and tools for high-throughput drug screening. FAST-TRAC Awards are either one- or two-year grants, made in one-year allocations, with a maximum recommended funding of $150,000 per year. For larger budget requests please email science@cureangelman.org for justification. For applications and more information about FAST-TRAC Awards see here.

In an effort to attract excellent young researchers to join the field of AS, these awards are granted to promising new scientists looking to start a significant research program focusing on translational research. Applicants are within their first five years of an academic position at an institution/university. New Investigator Awards are either one- or two- year grants, made in one-year allocations, with a maximum recommended funding of $150,000 per year. For larger budget requests please email science@cureangelman.org for justification. For applications and more about New Investigator Awards see here.

The FAST IMPACT (Innovative Methods to Advance Angelman Syndrome Treatments Towards Clinical Trials) Award is available to provide substantial support for comprehensive, translational research platform projects, spanning from pre-clinical research to human candidate drugs, which can then be advanced to the stage where Investigational New Drug (IND) application preparation is enabled. The FAST IMPACT grant welcomes proposals from researchers presenting innovative ideas and exciting proof-of-concept work, with the laser focus of advancing therapeutic opportunities to humans living with Angelman syndrome. Award amounts for a FAST IMPACT Grant can be up to $1,000,000 per year. For applications and more about FAST IMPACT Awards, see here.

Fellowships provide the necessary resources to support and encourage the development of young scientists who benefit from the mentorship of prominent researchers. Applicants must hold a postdoctoral fellowship position at an institution/university at the time of award submission and throughout the proposed awarded period. The hope is that our fellows will later assume professorial roles in departments around the world, which currently have no representation in Angelman syndrome research to further the mission of FAST. Applicants may request up to $50,000 per year for up to two years for salary, fringe benefits, and consumable costs. For applications and more information about The FAST Postdoctoral Fellowship Awards see here.

The Innovation Seed Grant is a funding opportunity designed to support innovative proof-of-concept research to advance the understanding and treatment of Angelman Syndrome. With grant amounts ranging from $10,000 to $50,000, this program encourages groundbreaking research ideas that have the potential to make a significant impact on the field. The grant is open to both individual researchers and collaborative teams, including partnerships between academic institutions and industry entities. Proposals should focus on novel, high-risk, high-reward approaches that could lead to transformative advancements in the treatment, therapeutic target, or biomarker identification for Angelman syndrome. This seed funding is intended to help investigators demonstrate early-stage feasibility and provide FAST scientific proof of principal data needed to apply for potential larger-scale funding opportunities.

Apply now.